Vertigo, a common clinical symptom characterized by the perception of motion where none exists, can be a diagnostic challenge for healthcare professionals. Understanding the pathophysiology and clinical approach to vertigo is paramount to ensure effective patient management.
Vertigo is primarily a manifestation of vestibular dysfunction. It arises from an imbalance in the neuronal activity of the bilateral vestibular nuclei. This can be due to peripheral causes like benign paroxysmal positional vertigo (BPPV), Meniere's disease, or vestibular neuritis, or central causes such as cerebrovascular disease or migraines.
The clinical approach to vertigo begins with a detailed history and physical examination. The temporal pattern of vertigo, associated symptoms like tinnitus or hearing loss, and provoking factors should be thoroughly evaluated. Physical examination should include Dix-Hallpike and head impulse tests.
Basic investigations include complete blood counts, electrolytes, and imaging studies. More specific tests like electronystagmography (ENG), videonystagmography (VNG), or magnetic resonance imaging (MRI) may be necessary based on the clinical suspicion. Audiometric studies can be useful in cases of suspected Meniere's disease.
Management of vertigo depends on the underlying cause. BPPV can be managed with canalith repositioning maneuvers while vestibular suppressants are used for vestibular neuritis. For Meniere's disease, a combination of dietary modification and diuretics is often effective. In refractory cases, vestibular rehabilitation therapy or surgery may be considered.
Vertigo is a complex symptom that requires a comprehensive clinical approach for accurate diagnosis and effective management. A clear understanding of its pathophysiology, clinical presentation, diagnostic investigations, and management strategies will enhance the ability of healthcare professionals to provide optimal patient care.
1.
Trial Supports Ivonescimab and Chemo for NSCLC Survival
2.
Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.
3.
Lymph node transfer reduces arm swelling after breast cancer surgery, study shows
4.
Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.
5.
Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?
1.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
2.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
3.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
4.
Uncovering the Mysteries of the RDW Blood Test
5.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part II
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Navigating the Complexities of Ph Negative ALL - Part XIV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation